EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia

Kenji Hashimoto

Recent Patents on CNS Drug Discovery · 2006

DOI: 10.2174/157488906775245336 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recent Patents on CNS Drug Discovery, 2006. Verfasst von Kenji Hashimoto. Beteiligte Einrichtung: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp. Die Arbeit wurde bisher 28-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsBenzamidesGlutamic AcidGlycineGlycine Plasma Membrane Transport ProteinsHumansPiperidinesSchizophrenia

Substanzen

2-chloro-N-((S)-phenyl((2S)-piperidin-2-yl)methyl)-3-trifluoromethyl benzamideBenzamidesGlycine Plasma Membrane Transport ProteinsPiperidinesSLC6A9 protein, humanGlutamic AcidGlycine

Autor:innen und Institutionen

  • Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp

Zitieren

APA

Hashimoto, K. (2006). Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia. Recent Patents on CNS Drug Discovery. https://doi.org/10.2174/157488906775245336

Vancouver

Hashimoto K. Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia. Recent Patents on CNS Drug Discovery. 2006. doi:10.2174/157488906775245336

BibTeX
@article{Hashimoto2006,
  author = {Hashimoto, Kenji},
  title = {Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia},
  journal = {Recent Patents on CNS Drug Discovery},
  year = {2006},
  doi = {10.2174/157488906775245336}
}
Kostenlos starten →